Global Digital PCR and Real-Time PCR Market Size is valued at USD 8.8 billion in 2024 and is predicted to reach USD 18.9 billion by the year 2034 at an 8.0% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
Digital PCR is an end-point PCR method for absolute quantification and analyzing minority sequences against a backdrop of similar majority sequences. Digital PCR (dPCR) allows for the exact and sensitive measurement of nucleic acids. Real time PCR is a method for collecting data during the PCR process, integrating amplification and detection into a single phase. Nucleic acid quantification using real-time quantitative PCR is sensitive, specific, and repeatable. It monitors the amplification of a specific DNA molecule throughout the PCR.
The rising prevalence of genetic disorders and major infectious diseases, increased use of biomarker profiling for disease diagnosis, and the successful completion of the Human Genome Project are the primary factors driving demand for technologically advanced PCR tests during the forecast period. Significant technological developments, increased investments, funding, and grants are expected to raise demand for digital PCR in various applications in the next years.
However, the COVID-19 pandemic has significantly impacted the healthcare industry. Digital PCR and real-time PCR have generated considerable interest due to their use in diagnostics and drug discovery. Therefore, industry suppliers are actively developing droplet digital PCR assays for COVID-19 detection. In addition, numerous participants in the industry have developed unique instruments and tests for COVID-19 testing.
The digital PCR and real-time PCR market is segmented on the basis of product & service, application, and end-user. The product & service segment includes QPCR (QPCR reagents and consumables, QPCR instruments, QPCR software and services), DPCR (DPCR reagents and consumables, DPCR instruments, DPCR software and services). DPCR instruments are further segmented into chip-based digital PCR and beaming digital PCR. On the basis of QPCR application, the market is segmented into clinical applications (infectious disease testing, oncology testing, blood screening, transplant diagnostics, other clinical applications), research applications, forensic applications, environmental applications, and other applications. The end-user segment includes Hospitals and diagnostic laboratories, academic & research institutes, pharmaceutical & biotechnology, CROS & CDMOS, forensic laboratories, and other end-users.
The hospitals and diagnostic laboratories category is expected to hold a considerable share in the global Digital PCR and Real-Time PCR Market in 2024 owing to the rising availability of qPCR reagents in the market. The use of clinical diagnostics and the continual growth of healthcare infrastructure in emerging markets, and the increasing prevalence and incidence of target diseases such as HIV/AIDS, cancer, malaria, and tuberculosis are likely to drive demand for hospital and diagnostic facilities in the Digital PCR (dPCR) and Real-Time PCR (qPCR) markets. The growing awareness among End-Users about the benefits of qPCR ineffective and speedy illness diagnosis is projected to fuel the growth of the Digital PCR (dPCR) and Real-Time PCR (qPCR) Markets in the coming years.
The QPCR & DPCR reagents and consumables segment is projected to expand at a rapid rate in the global Digital PCR and Real-Time PCR Market. This can be ascribed to the COVID-19 pandemic, increased demand for early illness detection, and the number of prominent companies producing digital PCR consumables and reagents. Furthermore, the widespread usage of consumables and reagents and the growing demand for healthcare, research, and other uses contribute to the segment's substantial share. Furthermore, the category is expected to keep its lead during the forecast period.
The North America Digital PCR and Real-Time PCR Market is expected to register the highest market share in terms of revenue in the near future, primarily due to the presence of favourable rules and many government efforts aimed at developing healthcare infrastructure, as well as the region's high disease prevalence. Furthermore, the region's strong presence of significant manufacturers and an increasing need for rapid diagnostic tests are projected to be critical factors driving the North American market throughout the projection period.
Due to the significant developments by China and Japan for technological integration of PCR methodologies, as well as the development of healthcare, R&D, and clinical development frameworks by emerging economies such as India and Australia, Asia Pacific is the most lucrative market. Throughout the projection period, the industry will see profitable growth possibilities.
|
Report Attribute |
Specifications |
|
Market size value in 2024 |
USD 8.8 Billion |
|
Revenue forecast in 2034 |
USD 18.9 Billion |
|
Growth rate CAGR |
CAGR of 8.0% from 2025 to 2034 |
|
Quantitative units |
Representation of revenue in US$ Bn, and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Product & Service, Application, And End-User |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
Danaher Corporation, F. Hoffmann-LA Roche Ltd., Thermo Fisher Scientific Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Takara Bio Inc., Becton, Dickson and Company, Abbott Laboratories, Promega Corporation, Merck KGAA, Endress+Hauser, Biomerieux, Meridian Bioscience, Eppendorf AG, Quidel Corporation, Standard Biotools, Enzo Biochem, Inc., Stilla Technologies, JN Medsys PTE, LTD. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Digital PCR and Real-Time PCR Market Snapshot
Chapter 4. Global Digital PCR and Real-Time PCR Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product & Service Estimates & Trend Analysis
5.1. by Product & Service & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product & Service:
5.2.1. qPCR Products & Services
5.2.1.1. qPCR Reagents and Consumables
5.2.1.2. qPCR Instruments
5.2.1.3. qPCR Software and Services
5.2.2. dPCR Products & Services
5.2.2.1. dPCR Instruments
5.2.2.1.1. Droplet PCR
5.2.2.1.2. Chip-based PCR
5.2.2.1.3. BEAMing Digital PCR
5.2.2.2. dPCR Reagents and Consumables
5.2.2.3. dPCR Software and Services
Chapter 6. Market Segmentation 2: by End-user Estimates & Trend Analysis
6.1. by End-user & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-user:
6.2.1. Hospitals and Diagnostic Laboratories
6.2.2. Academic and Research Institutes
6.2.3. Pharmaceutical and Biotechnology Companies
6.2.4. CROs and CDMOs
6.2.5. Forensic Laboratories
6.2.6. Other End Users
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
7.2.1. Clinical Applications
7.2.2. Infectious Disease Testing
7.2.3. Oncology Testing
7.2.4. Blood Screening
7.2.5. Transplant Diagnostics
7.2.6. Other Clinical Applications
7.2.7. Research Applications
7.2.8. Forensic Applications
7.2.9. Environmental Applications
7.2.10. Other Applications
Chapter 8. Digital PCR and Real-Time PCR Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Digital PCR and Real-Time PCR Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2021-2034
8.1.2. North America Digital PCR and Real-Time PCR Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.1.3. North America Digital PCR and Real-Time PCR Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.1.4. North America Digital PCR and Real-Time PCR Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Digital PCR and Real-Time PCR Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2021-2034
8.2.2. Europe Digital PCR and Real-Time PCR Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.2.3. Europe Digital PCR and Real-Time PCR Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.2.4. Europe Digital PCR and Real-Time PCR Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Digital PCR and Real-Time PCR Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2021-2034
8.3.2. Asia Pacific Digital PCR and Real-Time PCR Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.3.3. Asia-Pacific Digital PCR and Real-Time PCR Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.3.4. Asia Pacific Digital PCR and Real-Time PCR Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Digital PCR and Real-Time PCR Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2021-2034
8.4.2. Latin America Digital PCR and Real-Time PCR Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.4.3. Latin America Digital PCR and Real-Time PCR Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.4.4. Latin America Digital PCR and Real-Time PCR Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Digital PCR and Real-Time PCR Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2021-2034
8.5.2. Middle East & Africa Digital PCR and Real-Time PCR Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.5.3. Middle East & Africa Digital PCR and Real-Time PCR Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.5.4. Middle East & Africa Digital PCR and Real-Time PCR Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.2. Agilent Technologies, Inc.
9.2.3. Analytik Jena AG
9.2.4. Becton Dickinson and Company
9.2.5. Bio Molecular Systems
9.2.6. Biomeme Inc.
9.2.7. Biomérieux S.A.
9.2.8. Bioneer Corporation
9.2.9. Bio-Rad Laboratories, Inc.
9.2.10. Cole-Parmer Instrument Company Llc
9.2.11. Danaher Corporation
9.2.12. Elitech Group Sas
9.2.13. Endress+Hauser
9.2.14. Enzo Life Sciences, Inc.
9.2.15. Eppendorf AG
9.2.16. F. Hoffmann-LA Roche Ltd.
9.2.17. Fluidigm Corporation
9.2.18. JN Medsys PTE, LTD.
9.2.19. Merck KGAA
9.2.20. Meridian Bioscience, Inc.
9.2.21. Promega Corporation
9.2.22. Qiagen N.V.
9.2.23. Quidel Corporation
9.2.24. Quanta Biosciences Inc.
9.2.25. Sacace Biotechnologies Srl
9.2.26. Standard Biotools
9.2.27. Stilla Technologies
9.2.28. Takara Bio, Inc.
9.2.29. Thermo Fisher Scientific, Inc.
9.2.30. Other Prominent Players
Digital PCR and Real-Time PCR Market By Product-& Services
Digital PCR and Real-Time PCR Market By Application-
Digital PCR and Real-Time PCR Market By End-User-
Digital PCR and Real-Time PCR Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
